Author(s)

Madjara Anoumatacky^1,2,3, Anna-Corinne Bissouma^2,3, Drissa Kone⁴

¹Laboratory of Biology and Health, Department of Biosciences, Félix Houphouet-Boigny University, Abidjan, Côte d’Ivoire.
²National Mental Health Program, Abidjan, Côte d’Ivoire.
³Centre Marguerite Té-Bonlé, National Institute of Public Health, Abidjan, Côte d’Ivoire.
⁴Department of Medical Sciences, Félix Houphouet-Boigny University, Abidjan, Côte d’Ivoire.

Schizophrenia is classified as a priority mental disorder by the World Health Organization (WHO) and accounts for around 35% of diagnoses at the Bingerville Psychiatric Hospital (HPB). The aims of the study were to identify the cost drivers for hospitalization and to calculate the costs of managing schizophrenia in hospital, with a view to planning household expenditure on care. This pilot cross-sectional study involved 31 patients with schizophrenia who had been hospitalized in the various third-category wards at the HPB between 1st January 2019 and 31st May 2020. Sampling was accidental. The methods used to estimate costs were based on the actual costs of drugs, hospitalization and additional examinations which prices were known, and on patients’ estimations for certain expenses such as food and transport. Results: The sex ratio was 3.42, the mean age was 29.52 years. The mean length of stay was 46.19 days, and the most frequent clinical forms were paranoid schizophrenia (41.9%) and schizoaffective disorder (29%). The combination of haloperidol and chlorpromazine was the most common medications for initial treatment (67.8%) and maintenance treatment (41.9%). The average cost of hospitalization at HPB for schizophrenia was XOF 164,412 (€249.90). The average direct medical cost was XOF 105,412 (€160.226) and the average direct non-medical cost was XOF 59,000 (€89.68). The average daily cost of antipsychotic treatment was XOF 795/day (€1.2084). The high cost of drugs as a proportion of hospitalization costs suggested the need of a reflection on the simplification of prescribing practices, assistance in psychiatric emergencies and the development of other alternatives to psychiatric hospitalization in Côte d’Ivoire.

Schizophrenia, Cost, Hospitalization, HPB, Côte d’Ivoire

Anoumatacky, M. , Bissouma, A. and Kone, D. (2024) Costs of Schizophrenia at Psychiatric Hospital of Bingerville (Ivory Coast). Open Journal of Psychiatry, 14, 1-10. doi: 10.4236/ojpsych.2024.141001.